Researchers at the University of Chicago have found that Vitamin D deficiency is associated with a higher likelihood of contracting the coronavirus. In combination with other Vitamin D research, the results may point the way to a quick and inexpensive way to reduce COVID-19 deaths among African-Americans and Hispanics.
David Meltzer, MD, Ph.D, lead author of the article published September 3rd in JAMA Network Open, discussed their findings on a University of Chicago Medicine website. “Vitamin D is important to the function of the immune system and vitamin D supplements have previously been shown to lower the risk of viral respiratory tract infections. Our statistical analysis suggests this may be true for the COVID-19 infection.”
Another study from Spain, published August 29, had test and control groups well-matched for age, sex, comorbidities and clinical indications of COVID-19 severity. In the control group, 50% were admitted to ICU and two died. In addition to the same drugs given to the control group, the test group was given calcifediol, a vitamin D analog, which increases vitamin D levels in the body. The test group had no deaths and only 2% had to be admitted to the ICU. Continue reading